The etiological importance of reduced B-cell masses for the development of type 2 diabetes mellitus.

B 细胞质量减少对于 2 型糖尿病发生的病因学重要性。

基本信息

  • 批准号:
    09671061
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

In this study, we tried to explore whether an impairment of insulin secretion observed in type 2 diabetes mellitus is caused by the reduction of beta -cell mass using OLETF rats, a model of type 2 diabetes. The following results have been obtained ;1. A failure in the compensative proliferation of pancreatic beta-cells has been reported in the OLETF rat. The present study was undertaken to define whether the defect is involved in its fetal model. The defective morphogenesis of endocrine cells and functional adaptation to increased metabolic demand could be thought of as a failure involved in the fetal model, and a decreased expression of PDX- 1 may be one of the factors which contribute to this failure in this model rat.2. Hypertriglyceridemia resulted in significant TG stores in the islets, which subsequently inhibited glucose-induced insulin secretion, at least in part, via reduced glucokinase activity in the islets Fat droplets in the islets may play an important role in hastening the development of diabetes mellitus in this rat model.3. The fine capillaries that form a network in the islets were extremely sparse in the OLETF rat, resulting in a defective glomerular-like configuration, whereas those from the control rat (LETO) were dense, forming a nearlv typical glomerular-like configuration.4. Wistar fatty rat, another type 2 model, has a poor capacity for proliferation of pancreatic beta -cells, which causes the onset of overt diabetes along with insulin resistance due to extreme obesity just like OLETF rats.
在本研究中,我们试图探索在2型糖尿病中观察到的胰岛素分泌障碍是否是由使用OLETF大鼠(2型糖尿病模型)的β细胞质量减少引起的。取得了以下成果:1.据报道,OLETF大鼠中胰腺β细胞代偿性增殖失败。本研究是为了确定缺陷是否涉及其胎儿模型。内分泌细胞的形态发生缺陷和对代谢需求增加的功能适应可以被认为是胎儿模型中涉及的失败,并且PDX- 1的表达降低可能是导致该模型大鼠中这种失败的因素之一。高甘油三酯血症导致胰岛中显著的TG储存,其随后至少部分地通过降低胰岛中的葡萄糖激酶活性来抑制葡萄糖诱导的胰岛素分泌。胰岛中的脂肪滴可能在加速该大鼠模型中糖尿病的发展中起重要作用。OLETF大鼠胰岛中形成网络的细小毛细血管非常稀疏,导致有缺陷的肾小球样构型,而对照大鼠(LETO)的毛细血管密集,形成近典型的肾小球样构型.另一种2型模型Wistar肥胖大鼠胰腺β-细胞增殖能力差,这导致明显的糖尿病沿着由于极度肥胖引起的胰岛素抵抗的发作,就像OLETF大鼠一样。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Zhu: "Ovarian hormone-induced beta-cell hypertrophy contributes to the homeostatic control of beta-cell mass in OLETF female rat,a model of type2 diabetes." Diabetologia. 41. 799-805 (1998)
M.Zhu:“卵巢激素诱导的 β 细胞肥大有助于 OLETF 雌性大鼠(2 型糖尿病模型)β 细胞质量的稳态控制。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Toide, Z.W.Man, Y.Asahi, T.Sato, N.Nakayama, Y.Noma, Y.Oka, K.Shima: "Glucose transporter levels in a male spontaneous non-insulin-dependent deabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain." Diab.Res.Cin.Pract. 38. 151-161 (1997)
K.Toide、Z.W.Man、Y.Asahi、T.Sato、N.Nakayama、Y.Noma、Y.Oka、K.Shima:“大冢雄性自发性非胰岛素依赖性糖尿病大鼠的葡萄糖转运蛋白水平
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A.Mizuno, M.Kuwajima, K.Ishida, Y.Noma, T.Murakami, K.Tateishi, I.SatoandK.Shima: "Extrapancreatic action of truncated glucagon-like peptide-1 in Otsuka Long-Evans Tokushima Fatty rats, an animal model for non-insulin-dependent diabetes mellitus." Metabol
A.Mizuno、M.Kuwajima、K.Ishida、Y.Noma、T.Murakami、K.Tateishi、I.Sato 和 K.Shima:“截短的胰高血糖素样肽-1 在大冢 Long-Evans 德岛脂肪大鼠中的胰外作用,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Akira Mizuno: "Extrapancreatic action of truncated glucagon-like peptide-I in Otsuka Long-Evans Tokushima Fatty rat,an annimal model for Non-Insulin-Dependent Diabetes Mellitus." Metabolism. 46(7). 745-749 (1997)
Akira Mizuno:“截短的胰高血糖素样肽-I 在大冢朗-埃文斯德岛脂肪大鼠中的胰外作用,这是一种非胰岛素依赖性糖尿病的动物模型。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Shima, M.Zhu, Y.Noma, A.Mizuno, T.Murakami, T.Sano and M.Kuwajima: "Exercise training in Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin dependent diabetes mellitus : effects on the B-cell mass, insulin content and fibrosis in
K.Shima、M.Zhu、Y.Noma、A.Mizuno、T.Murakami、T.Sano 和 M.Kuwajima:“大冢朗-埃文斯德岛肥胖大鼠的运动训练,一种自发性非胰岛素依赖型糖尿病模型
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIMA Kenji其他文献

SHIMA Kenji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIMA Kenji', 18)}}的其他基金

Studies on enterohepatic axis
肠肝轴研究
  • 批准号:
    59480254
  • 财政年份:
    1984
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

LEPTIN REGULATION OF BETA CELL PROLIFERATION
瘦素对 β 细胞增殖的调节
  • 批准号:
    10625939
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Circadian Regulation of Beta Cell Proliferation
β细胞增殖的昼夜节律调节
  • 批准号:
    574644-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    University Undergraduate Student Research Awards
Role of the GPR3-SIK2 Pathway in Human Beta Cell Proliferation
GPR3-SIK2 通路在人 β 细胞增殖中的作用
  • 批准号:
    462043
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
Targeting 14-3-3zeta to increase beta-cell proliferation and function to treat Type 1 Diabetes
靶向 14-3-3zeta 增加 β 细胞增殖和功能以治疗 1 型糖尿病
  • 批准号:
    468316
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
Epigenetic regulation in therapeutic human pancreatic beta cell proliferation
治疗性人胰腺β细胞增殖的表观遗传调控
  • 批准号:
    10192020
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
Epigenetic regulation in therapeutic human pancreatic beta cell proliferation
治疗性人胰腺β细胞增殖的表观遗传调控
  • 批准号:
    10364701
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
Role of the GPR3-SIK2 Pathway in Human Beta Cell Proliferation
GPR3-SIK2 通路在人 β 细胞增殖中的作用
  • 批准号:
    456702
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
Investigating the effects of maternal folic acid over-supplementation on offspring beta-cell proliferation, epigenetic regulation of genes, and vascularization of the pancreas
研究母亲过量补充叶酸对后代 β 细胞增殖、基因表观遗传调控和胰腺血管化的影响
  • 批准号:
    458998
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Studentship Programs
Epigenetic regulation in therapeutic human pancreatic beta cell proliferation
治疗性人胰腺β细胞增殖的表观遗传调控
  • 批准号:
    10532768
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
Establishment of an experimental system to evaluate pancreatic beta-cell proliferation in vitro that can be utilized to identify anti-diabetes therapeutics targeting pancreatic beta-cell mass
建立体外评估胰腺 β 细胞增殖的实验系统,可用于识别针对胰腺 β 细胞群的抗糖尿病疗法
  • 批准号:
    21K19504
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了